BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26388174)

  • 1. Genetics affect IPF treatment response to N-acetylcysteine.
    Lozano-Wilhelmi M
    Lancet Respir Med; 2015 Oct; 3(10):752. PubMed ID: 26388174
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination therapies targeting multiple pathways in idiopathic pulmonary fibrosis (IPF).
    Taniguchi H; Kondoh Y
    Intern Med; 2013; 52(22):2481-2. PubMed ID: 24240784
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression].
    Entzian P
    Pneumologie; 1998 Jul; 52(7):396-7. PubMed ID: 9738391
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination pirfenidone and inhaled N-acetylcysteine therapy for IPF: does it take these two to tango?
    Velez MI; Nambiar AM
    Respirology; 2015 Apr; 20(3):359-60. PubMed ID: 25678074
    [No Abstract]   [Full Text] [Related]  

  • 5. Triple therapy in idiopathic pulmonary fibrosis: an alarming press release.
    Wells AU; Behr J; Costabel U; Cottin V; Poletti V
    Eur Respir J; 2012 Apr; 39(4):805-6. PubMed ID: 22467722
    [No Abstract]   [Full Text] [Related]  

  • 6. Hot off the breath: A big step forward for idiopathic pulmonary fibrosis.
    Ryerson CJ; Collard HR
    Thorax; 2014 Sep; 69(9):791-2. PubMed ID: 24996636
    [No Abstract]   [Full Text] [Related]  

  • 7. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats.
    Li S; Yang X; Li W; Li J; Su X; Chen L; Yan G
    Respiration; 2012; 84(6):509-17. PubMed ID: 23006535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How to face the current status of therapies for idiopathic pulmonary fibrosis].
    Zhang DP
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):844-7. PubMed ID: 24507398
    [No Abstract]   [Full Text] [Related]  

  • 9. N-acetylcysteine for chronic obstructive pulmonary disease?
    Lavietes MH
    Respiration; 1999; 66(6):491-2. PubMed ID: 10847827
    [No Abstract]   [Full Text] [Related]  

  • 10. N-acetylcysteine in COPD may be beneficial, but for whom?
    Cazzola M; Matera MG
    Lancet Respir Med; 2014 Mar; 2(3):166-7. PubMed ID: 24621673
    [No Abstract]   [Full Text] [Related]  

  • 11. [Idiopathic pulmonary fibrosis: A new era, new challenges].
    Cottin V
    Rev Mal Respir; 2014 Sep; 31(7):583-6. PubMed ID: 25239578
    [No Abstract]   [Full Text] [Related]  

  • 12. N-acetylcysteine for COPD: the evidence remains inconclusive.
    Turner RD; Bothamley GH
    Lancet Respir Med; 2014 Apr; 2(4):e3. PubMed ID: 24717631
    [No Abstract]   [Full Text] [Related]  

  • 13. N-acetylcysteine for COPD: the evidence remains inconclusive--authors' reply.
    Zheng JP; Zhong NS
    Lancet Respir Med; 2014 Apr; 2(4):e3-4. PubMed ID: 24717632
    [No Abstract]   [Full Text] [Related]  

  • 14. N-Acetylcysteine for the prevention of renal dysfunction in high-risk patients undergoing coronary bypass graft surgery: an unfulfilled promise?
    Filep JG
    Crit Care Med; 2007 May; 35(5):1431-3. PubMed ID: 17446744
    [No Abstract]   [Full Text] [Related]  

  • 15. N-acetylcysteine somewhere between Scylla and Charybdis.
    Sochman J
    J Am Coll Cardiol; 2010 Sep; 56(13):1067; author reply 1067-8. PubMed ID: 20846610
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical N-acetylcysteine for the treatment of lamellar ichthyosis: an improved formula.
    Davila-Seijo P; Flórez A; Davila-Pousa C; No N; Ferreira C; De la Torre C
    Pediatr Dermatol; 2014; 31(3):395-7. PubMed ID: 24602057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regarding "comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning" by Yarema et al.
    Hernandez SH; Ghaffari G; Connors NJ; Howland MA; Hoffman RS
    Ann Emerg Med; 2009 Dec; 54(6):856-7. PubMed ID: 19942074
    [No Abstract]   [Full Text] [Related]  

  • 18. Personalizing Therapy in Idiopathic Pulmonary Fibrosis: A Glimpse of the Future?
    Kropski JA; Lawson WE; Blackwell TS
    Am J Respir Crit Care Med; 2015 Dec; 192(12):1409-11. PubMed ID: 26669470
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical N-acetylcysteine in ichthyosis: Experience in 18 patients.
    Kaplan L; Castelo-Soccio L
    Pediatr Dermatol; 2018 Jul; 35(4):528-530. PubMed ID: 29582451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caring for the mother, concentrating on the fetus: intravenous N-acetylcysteine in pregnancy.
    Crowell C; Lyew RV; Givens M; Deering SH
    Am J Emerg Med; 2008 Jul; 26(6):735.e1-2. PubMed ID: 18606344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.